Chronic Lymphocytic Leukemia (CLL) Success with Combination Therapies

被引：0
|
作者：
Habel, Christoph
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [31] COMPLETE REMISSION (CR) IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) TREATED WITH COMBINATION CHEMOTHERAPY
    SCOUROS, M
    MURPHY, S
    HESTER, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 441 - 441
  • [32] Combination fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Garcia-Manero, G
    O'Brien, S
    Cortes, J
    Giles, F
    Faderl, S
    Lerner, S
    Albitar, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2000, 96 (11) : 757A - 757A
  • [33] The combination of rituximab and GM-CSF in elderly patients with chronic lymphocytic leukemia (CLL).
    Ferrajoli, A.
    O'Brien, S.
    Faderl, S.
    Wierda, W. G.
    Schlette, E.
    Jorgensen, J. L.
    Reuben, J. M.
    Albitar, M.
    Keating, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 361S - 361S
  • [34] Comparative analysis of targeted therapies in relapsed/refractory chronic lymphocytic leukemia (R/R CLL)
    Mato, Anthony
    Roeker, Lindsey
    Eyre, Toby
    Ujjani, Chaitra
    Lamanna, Nicole
    Hill, Brian
    Barr, Paul
    Lansigan, Erick
    Cheson, Bruce D.
    Yazdy, Maryam
    Allan, John
    Rhodes, Joanna
    Kennard, Kaitlin
    Schuster, Steven
    Nabhan, Chadi
    Skarbnik, Alan
    Goy, Andre
    Dorsey, Colleen
    Goodfriend, Julie
    Coombs, Catherine
    Tuncer, Hande H.
    Pagel, John
    Jacobs, Ryan
    Kirkwood, Amy
    Winter, Allison
    Schuh, Anna
    Bailey, Neil
    Sitlinger, Andrea
    Shadman, Mazyar
    Fox, Christopher
    Brander, Danielle
    LEUKEMIA & LYMPHOMA, 2020, 61 : 193 - 195
  • [35] New Therapies for Chronic Lymphocytic Leukemia
    Robak, Pawel
    Robak, Tadeusz
    CURRENT CANCER THERAPY REVIEWS, 2013, 9 (04) : 245 - 257
  • [36] Sequencing of chronic lymphocytic leukemia therapies
    Barrientos, Jacqueline C.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 128 - 136
  • [37] Novel therapies for chronic lymphocytic leukemia
    Mavromatis, BH
    Cheson, BD
    BLOOD REVIEWS, 2004, 18 (02) : 137 - 148
  • [38] Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Jaglowski, Samantha M.
    Jones, Jeffrey A.
    Flynn, Joseph M.
    Andritsos, Leslie A.
    Maddocks, Kami J.
    Woyach, Jennifer A.
    Blum, Kristie A.
    Greyer, Michael R.
    Geyer, Susan Michelle
    Heerema, Nyla A.
    Lozanski, Gerard
    Stefanos, Mona
    Hall, Nathan
    Nagar, Veena
    Munneke, Brian
    West, Jamie-Sue
    Neuenburg, Jutta K.
    James, Danelle F.
    Johnson, Amy J.
    Byrd, John C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S206 - S207
  • [39] Prevalence, screening, treatment, and complications of osteoporosis and osteopenia in Medicare patients with chronic lymphocytic leukemia (CLL).lepatients with chronic lymphocytic leukemia (CLL).
    Brander, Danielle M.
    Oeffinger, Kevin C.
    Greiner, Melissa A.
    Dinan, Michaela Ann
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] PREDICTORS OF INFECTION IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    GRIFFITHS, H
    LEA, J
    BUNCH, C
    LEE, M
    CHAPEL, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1992, 89 (03): : 374 - 377
12345